Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Protein kinase inhibitors and their use in the treatment of cancer presented by Agouron

March 5, 2001

Novel Nippon Kayaku compounds inhibit tumor cell proliferation

March 5, 2001

Antitumor phosphoramide compounds designed at Purdue

March 5, 2001

Aventis's new vector complexes useful in gene therapy of cancer

March 5, 2001

Faulding to market and sell NaPro's paclitaxel in Europe

March 5, 2001

Introgen's INGN-241 shows antitumor activity against human melanoma

March 5, 2001

Arglabin-DMA acts as an inhibitor of posttranslational processing of Ras protein

March 5, 2001

Millennium begins phase II clinical trial of LDP-341 for treatment of multiple myeloma

March 5, 2001

Regulatory submissions filed for novel STI targeting abnormal protein in CML

March 2, 2001

Antineoplastic coumarone analogues identified at Sankyo

March 2, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...